Cardio Diagnostics Holdings, Inc. Operating Expenses
Cardio Diagnostics Holdings, Inc. (CDIO) reported Operating Expenses of $1.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. operating expenses for the quarter ending 2026-06-30 was $1.50M, a 10.83% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. operating expenses for the quarter ending 2026-03-31 was $1.79M, a 9.56% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating expenses for the quarter ending 2025-12-31 was $1.47M, a 3.56% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. operating expenses for the quarter ending 2025-09-30 was $1.71M, a 21.12% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. operating expenses for fiscal 2025 was $6.50M, a 22.64% decline from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. operating expenses for fiscal 2024 was $8.40M, a 15.72% increase from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. operating expenses for fiscal 2023 was $7.26M, a 59.57% increase from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. operating expenses for fiscal 2022 was $4.55M, a 632.18% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.50M 10-Q · filed 2026-08-07 | $3.29M 10-Q · filed 2026-08-07 | $4.76M derived: sum of 3 quarters · filed 2026-08-07 | $6.47M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.79M 10-Q · filed 2026-05-15 | $3.25M derived: sum of 2 quarters · filed 2026-05-15 | $4.97M derived: sum of 3 quarters · filed 2026-05-15 | $6.65M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $3.18M derived: sum of 2 quarters · filed 2026-03-13 | $4.87M derived: sum of 3 quarters · filed 2026-08-07 | $6.50M 10-K · filed 2026-03-13 |
| 2025-09-30 | $1.71M 10-Q · filed 2025-11-12 | $3.40M derived: sum of 2 quarters · filed 2026-08-07 | $5.03M 10-Q · filed 2025-11-12 | $6.55M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.69M 10-Q · filed 2026-08-07 | $3.32M 10-Q · filed 2026-08-07 | $4.84M derived: sum of 3 quarters · filed 2026-08-07 | $6.25M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $1.63M 10-Q · filed 2026-05-15 | $3.15M derived: sum of 2 quarters · filed 2026-05-15 | $4.57M derived: sum of 3 quarters · filed 2026-05-15 | $5.86M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $2.94M derived: sum of 2 quarters · filed 2026-03-13 | $4.23M derived: sum of 3 quarters · filed 2026-03-13 | $8.40M 10-K · filed 2026-03-13 |
| 2024-09-30 | $1.42M 10-Q · filed 2025-11-12 | $2.71M derived: sum of 2 quarters · filed 2025-11-12 | $6.88M 10-Q · filed 2025-11-12 | $8.43M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.29M 10-Q · filed 2025-08-14 | $5.46M 10-Q · filed 2025-08-14 | $7.01M derived: sum of 3 quarters · filed 2025-08-14 | $8.47M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.17M 10-Q · filed 2025-05-15 | $5.72M derived: sum of 2 quarters · filed 2025-05-15 | $7.18M derived: sum of 3 quarters · filed 2025-05-15 | $9.73M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $3.00M derived: sum of 2 quarters · filed 2025-03-20 | $5.56M derived: sum of 3 quarters · filed 2025-03-20 | $7.26M 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.45M 10-Q · filed 2024-11-13 | $4.01M derived: sum of 2 quarters · filed 2024-11-13 | $5.71M 10-Q · filed 2024-11-13 | $8.09M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $2.55M 10-Q · filed 2024-08-12 | $4.26M 10-Q · filed 2024-08-12 | $6.64M derived: sum of 3 quarters · filed 2024-08-12 | $7.79M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.70M 10-Q · filed 2024-05-15 | $4.08M derived: sum of 2 quarters · filed 2024-05-15 | $5.23M derived: sum of 3 quarters · filed 2024-05-15 | $6.02M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.53M derived: sum of 2 quarters · filed 2024-04-01 | $4.32M derived: sum of 3 quarters · filed 2024-04-01 | $4.55M 10-K · filed 2024-04-01 |
| 2022-09-30 | $1.15M 10-Q · filed 2023-11-13 | $1.94M derived: sum of 2 quarters · filed 2023-11-13 | $2.17M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $786.96K 10-Q · filed 2023-08-14 | $1.02M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $232.56K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $621.35K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |